Ledger.Open graph →
SEC Form D · filed July 9, 2021

Fuse Biotherapeutics, Inc

Offering
$7.1M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Yuanheng W. Liang · Los Angeles, CADirectorJeffrey Takimoto · Los Angeles, CAExecPaul Song · Los Angeles, CAExec · DirectorBrian Rabinovich · Los Angeles, CAExec · DirectorChristopher Pallotta · New York, NYExecYi Fan · Hong Kong, Hong KongExec · DirectorTrevor Bachand · HILLSBORO, ORExec · DirectorAshwin Datta · HILLSBORO, ORDirectorJacob A. Puig · Laredo, TXDirectorGerardo M. Sanchez · Laredo, TXExec · DirectorJamey A. Steen · Houston, TXExec · DirectorSteven Howard · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗